One Trial Should Not Rewrite the Rules: Experts Challenge New Paclitaxel Guidelines
Vascular specialists argue the ESVS revised its paclitaxel device guidance on the basis of a single Swedish trial, overlooking fifteen ...
Vascular specialists argue the ESVS revised its paclitaxel device guidance on the basis of a single Swedish trial, overlooking fifteen ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.